← SynDRA
TEPP-46
SynDRA canonical compound SYN0062909 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PKM |
|---|
| Mechanism of action | pyruvate kinase isozyme activator |
|---|
All known targets
Mechanisms of action (all sources)
- PKM ACTIVATOR
- pyruvate kinase isozyme activator
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CDC42
- PDE5A
- ALDH1A1
- KDM4E
- SMAD3
- RAPGEF3
- PTGS2
- PTGS1
- POLI
- PIN1
- NPSR1
- MBNL1
- MAPT
- L3MBTL1
- KDM4A
- ATM
- IDH1
- HDAC6
- GMNN
- GLP1R
- GLA
- GBA1
- GAA
- CGA
- CBX1
- BAZ2B
- ATXN2
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACTB
- CASP3
- CP2C9
- CP3A7
- GEMI
- KSYK
- PAK1
- RAC1
- RHG01
- SNCA
- SYK
- SYUA
- TP53
Cross-references
Synonyms
- RefChem:913719
- ML 265
- ML265
- MFCD23160747
- TEPP46
- MLS006010294
- orb1299971
- SCHEMBL15746500
- SCHEMBL29364842
- CHEBI:91563
- GTPL10555
- C17H16N4O2S2
- BDBM707442
- HMS3740A09
- HMS3872I03
- EX-A4305
- BDBM50455475
- s7302
- AKOS027322522
- CS-4865
- EBC-157207
- compound 46 [PMID: 20451379]
- NCGC00186528-01
- NCGC00186528-04
- NCGC00186528-07
- NCGC00186528-13
- NCGC00186528-17
- AC-35199
- AS-16621
- DA-47112
- FT161418
- HY-18657
- SMR004701362
- US20240409542, Example TEPP-46
- T7214
- BRD-A18279961-001-01-2
- Z3244811715
- TEPP-46 (ML265, CID-44246499, NCGC00186528)
- 6-[(3-aminophenyl)methyl]-4-methyl-2-methylsulfinyl-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone
Look up TEPP-46 in the interactive SynDRA portal →